High Net Worth Advisory Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$496K	Hold	1,500	–	–	0.12%	147
2025 Q4	$596K	Hold	1,500	–	–	0.14%	126
2025 Q3	$684K	Hold	1,500	–	–	0.16%	113
2025 Q2	$489K	Hold	1,500	–	–	0.13%	132
2025 Q1	$405K	Hold	1,500	–	–	0.11%	140
2024 Q4	$353K	Hold	1,500	–	–	0.1%	156
2024 Q3	$413K	Hold	1,500	–	–	0.12%	144
2024 Q2	$365K	Hold	1,500	–	–	0.11%	142
2024 Q1	$224K	Hold	1,500	–	–	0.07%	194
2023 Q4	$287K	Hold	1,500	–	–	0.11%	151
2023 Q3	$266K	Hold	1,500	–	–	0.11%	149
2023 Q2	$285K	Hold	1,500	–	–	0.11%	148
2023 Q1	$300K	Hold	1,500	–	–	0.12%	145
2022 Q4	$356K	Hold	1,500	–	–	0.14%	130
2022 Q3	$300K	Hold	1,500	–	–	0.13%	139
2022 Q2	$219K	Buy	1,500 +500	+50%	+$70.9K	0.09%	177
2022 Q1	$163K	Hold	1,000	–	–	0.06%	205
2021 Q4	$170K	Buy	+1,000	New	+$186K	0.06%	201